NHP data from$リジェネロン ファーマシューティカルズ(REGN.US)$'s new slide deck is very relevant for the weight loss space. Combining pure anti-Myostatin antibodies with Semaglutide was marginally effective in NHPs in preventing muscle loss. I believe that for that reason,$スカラー ロック ホールディングス(SRRK.US)$and probably also$バイオヘブン(BHVN.US)$are likely to disappoint. Additionally blocking other ligands like Activin A dramatically improves body composition. That is what$イーライ リリィ(LLY.US)$,$ケロス セラピューティクス(KROS.US)$...
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $キャンデル (CADL.US)$ after my disastrous SBFM.